• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[哮喘儿童流感疫苗的安全接种]

[Safe administration of influenza vaccine in asthmatic children].

作者信息

Kawahara H, Sakaguchi N, Iikura Y, Saito H, Akasawa A

机构信息

Department of Pediatrics, Showa Medical School.

出版信息

Arerugi. 1998 Jul;47(7):679-86.

PMID:9780443
Abstract

Thirty asthmatic children were examined allergic reaction against egg white, gelatin and vaccine solution before and after vaccination using skin prick test. We also measured the levels of specific IgE and IgG antibody against gelatin. The changes in clinical symptoms before and after vaccination were investigated in 25 asthmatic children by evaluating symptom and treatment score. The results were as follows; 1. In one subject who had delayed type of skin reaction to gelatin, the adverse reaction was also recognized at the skin site around 24 hrs after vaccination. In this subject, the levels of serum specific IgE and IgG to gelatin became positive after 5 months. 2. Specific IgE antibodies to gelatin were not detected in all subjects before and after vaccination. 3. The mean values of asthma symptom score before and after vaccination were 3.3 +/- 4.2 and 1.5 +/- 3.3 respectively. Those of treatment score before and after vaccination were 75.6 +/- 35.2 and 76.0 +/- 35.0 respectively. These results suggest that skin testing with gelatin and vaccine solution is useful as a screening method for predicting adverse reactions in asthmatic children and that influenza vaccination can be performed safely in skin test negative children.

摘要

30名哮喘儿童在接种疫苗前后,通过皮肤点刺试验检测了对蛋清、明胶和疫苗溶液的过敏反应。我们还测量了针对明胶的特异性IgE和IgG抗体水平。通过评估症状和治疗评分,对25名哮喘儿童接种疫苗前后的临床症状变化进行了调查。结果如下:1. 在一名对明胶有迟发型皮肤反应的受试者中,接种疫苗后约24小时在皮肤部位也出现了不良反应。在该受试者中,5个月后血清中针对明胶的特异性IgE和IgG水平呈阳性。2. 接种疫苗前后所有受试者均未检测到针对明胶的特异性IgE抗体。3. 接种疫苗前后哮喘症状评分的平均值分别为3.3±4.2和1.5±3.3。接种疫苗前后治疗评分的平均值分别为75.6±35.2和76.0±35.0。这些结果表明,用明胶和疫苗溶液进行皮肤试验作为预测哮喘儿童不良反应的筛查方法是有用的,并且在皮肤试验阴性的儿童中可以安全地进行流感疫苗接种。

相似文献

1
[Safe administration of influenza vaccine in asthmatic children].[哮喘儿童流感疫苗的安全接种]
Arerugi. 1998 Jul;47(7):679-86.
2
Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy.在对鸡蛋过敏的哮喘儿童中安全接种灭活病毒体佐剂流感疫苗。
Vaccine. 2008 Aug 26;26(36):4664-8. doi: 10.1016/j.vaccine.2008.06.095. Epub 2008 Jul 17.
3
Anaphylaxis from the influenza virus vaccine.流感病毒疫苗引起的过敏反应。
Int Arch Allergy Immunol. 2008;146(1):85-8. doi: 10.1159/000112507. Epub 2007 Dec 14.
4
Dermal testing of vaccines for children at high risk of allergies.
Vaccine. 2007 Apr 30;25(17):3454-63. doi: 10.1016/j.vaccine.2006.12.057. Epub 2007 Jan 11.
5
Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.病毒体亚单位灭活流感疫苗在哮喘儿童中的长期免疫原性
Vaccine. 2007 Sep 17;25(37-38):6692-8. doi: 10.1016/j.vaccine.2007.07.013. Epub 2007 Jul 27.
6
Safety of influenza vaccine administration in egg-allergic patients.鸡蛋过敏患者接种流感疫苗的安全性。
Pediatrics. 2010 May;125(5):e1024-30. doi: 10.1542/peds.2009-2512. Epub 2010 Apr 5.
7
[Immediate adverse reactions after administration of the influenza vaccine to patients with positive CAP-RAST to egg white].对蛋清CAP-RAST呈阳性的患者接种流感疫苗后的即时不良反应
Arerugi. 2002 Jul;51(7):559-64.
8
Antibody response to influenza vaccination in patients suffering from asthma.哮喘患者对流感疫苗接种的抗体反应。
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):583-9.
9
The safety and immunogenicity of influenza vaccine in children with asthma in Mexico.墨西哥哮喘儿童流感疫苗的安全性和免疫原性。
Int J Infect Dis. 2009 Jul;13(4):469-75. doi: 10.1016/j.ijid.2008.08.015. Epub 2008 Dec 11.
10
[Vaccinations of children allergic to eggs with vaccine prepared with egg].对鸡蛋过敏儿童接种用鸡蛋制备的疫苗
Arch Fr Pediatr. 1993 Mar;50(3):191-5.